SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: betty moyers who wrote (21233)4/23/1999 7:46:00 AM
From: Mkilloran  Read Replies (4) | Respond to of 23519
 
betty.......there has been much talk here on ALIBRA :
It's completing Phase III trials and will be submitted for NDA review around Sept.

Single dose size, stores at room temp, less expensive to produce, etc...

Here's a question to the board...

"WILL ALIBRA BE SOLD OVER THE COUNTER"
For those that think not..."WHY NOT"??????